Results 111 to 120 of about 7,469 (144)
Correction to "Fiberoptic Endoscopic Assessment of Dysphagia in a Patient With Cutaneous and Oropharyngeal Blisters". [PDF]
Clin Case Repeuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
European Journal of Dermatology, 2022
Bullous pemphigoid (BP) is relatively rare in the paediatric age group, with slightly more than 100 cases of BP reported in the literature. In this article, we focus on infantile BP (>= 28 days, <12 months), presenting a systematic review of cases of infantile BP in the literature from 1977 up to the present day. Fifty-four articles were selected,
Cozzani, Emanuele +4 more
openaire +2 more sources
Bullous pemphigoid (BP) is relatively rare in the paediatric age group, with slightly more than 100 cases of BP reported in the literature. In this article, we focus on infantile BP (>= 28 days, <12 months), presenting a systematic review of cases of infantile BP in the literature from 1977 up to the present day. Fifty-four articles were selected,
Cozzani, Emanuele +4 more
openaire +2 more sources
Autoimmunity Reviews, 2017
Bullous pemphigoid (BP) is the most common autoimmune bullous disorder which is characterized by autoantibodies against hemidesmosomal proteins of the skin and mucous membranes. Collagen XVII and dystonin-e have been identified as target antigens. BP affects mostly the elderly. The incidence of the disease is increasing gradually and is associated with
Işın Sinem, Bağcı +3 more
openaire +2 more sources
Bullous pemphigoid (BP) is the most common autoimmune bullous disorder which is characterized by autoantibodies against hemidesmosomal proteins of the skin and mucous membranes. Collagen XVII and dystonin-e have been identified as target antigens. BP affects mostly the elderly. The incidence of the disease is increasing gradually and is associated with
Işın Sinem, Bağcı +3 more
openaire +2 more sources
Characteristics of patients with bullous pemphigoid: comparison of classic bullous pemphigoid to non‐bullous pemphigoid [PDF]
Journal of the European Academy of Dermatology and Venereology, 2019 AbstractBackgroundBullous pemphigoid (BP) is the most common subepidermal autoimmune blistering disease. Patients occasionally present with a clinical picture of pruritus/urticaria alone for months and do not even develop blisters over time. Only few studies have investigated this subgroup of non‐bullous pemphigoid (NBP).ObjectiveTo evaluate the ...
Aviv Barzilai +10 more
openaire +2 more sources
Bullous pemphigoid and penicillamine
Clinical and Experimental Dermatology, 1996We describe a woman who developed bullous pemphigoid in association with penicillamine therapy. While pemphigus is a well-recognized complication of penicillamine, pemphigoid should also be considered in the differential diagnosis of bullous eruptions induced by this drug.
Richard Weller, Marion I White
openaire +3 more sources
Nature Reviews Disease Primers
Bullous pemphigoid is a chronic, subepidermal autoimmune blistering disease characterized by tense blisters on erythematous or normal skin that predominantly affects the older population. The disease arises from autoantibodies targeting hemidesmosomal proteins BP180 and BP230, which are crucial for dermal-epidermal adhesion.
Hossein Akbarialiabad +11 more
openaire +4 more sources
Bullous pemphigoid is a chronic, subepidermal autoimmune blistering disease characterized by tense blisters on erythematous or normal skin that predominantly affects the older population. The disease arises from autoantibodies targeting hemidesmosomal proteins BP180 and BP230, which are crucial for dermal-epidermal adhesion.
Hossein Akbarialiabad +11 more
openaire +4 more sources
Pathogenesis of Bullous Pemphigoid
Dermatologic Clinics, 2011Bullous pemphigoid, the most common autoimmune blistering disease, is induced by autoantibodies against type XVII collagen. Passive transfer of IgG or IgE antibodies against type XVII collagen into animals has revealed not only the pathogenicity of these antibodies but also the subsequent immune responses, including complement activation, mast cell ...
Hiroshi Shimizu +2 more
openaire +5 more sources
Dermatologic Clinics, 1987
Bullous pemphigoid is an acquired subepidermal blistering disease of the elderly characterized by tense blisters. Patients with bullous pemphigoid have circulating and tissue-bound antibodies that are directed against a normal component of the epidermal basement membrane.
openaire +3 more sources
Bullous pemphigoid is an acquired subepidermal blistering disease of the elderly characterized by tense blisters. Patients with bullous pemphigoid have circulating and tissue-bound antibodies that are directed against a normal component of the epidermal basement membrane.
openaire +3 more sources
Erythrodermic bullous pemphigoid is a clinical variant of bullous pemphigoid
British Journal of Dermatology, 1995Bullous pemphigoid (BP) is an autoimmune blistering disease of the skin. Several variants of BP have been described but until recently the relationship of these variants to generalized BP was unclear. Several studies have shown that pemphigoid nodularis, pemphigoid vegetans, localized BP and vesicular pemphigoid are true variants of BP as the ...
Neil J. Korman, S. G. Woods
openaire +3 more sources
The Prodrome of Bullous Pemphigoid
International Journal of Dermatology, 1988ABSTRACT: Bullous pemphigoid is an autoimmune bullous dermatosis that can be preceded by a prodromal phase, usually lasting weeks to months, during which the cutaneous changes are dermatitic rather than bullous. Two cases of unusually long prodromal periods, 18 months and 6 years, are reported.
Judith L. Silverstein +2 more
openaire +3 more sources